HCEMM-SU Cardiometabolic Immunology Research Group

Group Leader

Zoltán Varga

Group Leader

PERSONAL INFORMATION

Family name, First name: Varga, Zoltan
Date of birth: 28/FEB/1985
Researcher unique identifier:
Google Scholar: http://scholar.google.hu/citations?user=HiBwn6cAAAAJ&hl
ORCID: http://orcid.org/0000-0002-2758-0784
URL for web site: http://semmelweis.hu/pharmacology/zoltan-varga/

EDUCATION

01/SEPT/2009 – 12/DEC/2013 PhD
Department of Biochemistry, Faculty of Medicine, University of Szeged, Szeged, Hungary
01/SEPT/2003 – 27/JUNE/2009 Medical Doctor
Faculty of Medicine, University of Szeged, Szeged, Hungary
01/SEPT/2009 – 31/AUG/2011 English-Hungarian Medical Interpreter and Translator Postgraduate Course Faculty of Medicine, University of Szeged, Szeged, Hungary

CURRENT POSITION

01/NOV/2018 – Senior Research Associate
Department of Pharmacology and Pharmacotherapy, Faculty of Medicine, Semmelweis University, Budapest, Hungary

PREVIOUS POSITIONS

01/DEC/2011 – 31/AUG/2014 Junior Research Associate
Department of Pharmacology and Pharmacotherapy, Faculty of Medicine, Semmelweis University, Budapest, Hungary
01/SEPT/2014 – 07/JAN/2015 Assistant Professor
Department of Pharmacology and Pharmacotherapy, Faculty of Medicine, Semmelweis University, Budapest, Hungary
07/JAN/2015 – 11/JAN/2018 Visiting Fellow
Laboratory of Cardiovascular Physiology and Tissue Injury, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD., USA
01/FEB/2018 – 01/NOV/2018 Assistant Professor
Department of Pharmacology and Pharmacotherapy, Faculty of Medicine, Semmelweis University, Budapest, Hungary

FELLOWSHIPS AND AWARDS

2006, 2007, 2008, 2009: Scholarship of the Hungarian Republic
2006, 2007, 2008: Scholarship of the city Szeged
2007: Szent-Gyorgyi Albert Scholarship of the Rotary Club, Szeged
2007, 2008, 2009: IFMSA international training scholarships (Cairo, Egypt: General Surgery; Vienna, Austria: Vascular Surgery; Bangkok, Thailand: Obstetrics and Gynecology)
2013: Jedlik Ányos Predoctoral Scholarship, National Program of Excellence
2011, 2013: Master in Tutoring Award (award of the National Students’ Scientific Circle Council)
2009, 2011, 2013: Travel Grants of the International Society for Heart Research (ISHR)
2013: ISHR Early Career Investigator Grant
2014: Travel Grant of the European Society of Cardiology (ESC)
2014: First Contact Initiative Grant of the European Society of Cardiology (ESC)
2014: Merit award in scientific excellence, Semmelweis University
2015: Rosztoczy Foundation, Postdoctoral Fellowship
2017: Junior Prima Award

SUPERVISION OF GRADUATE STUDENTS AND POSTDOCTORAL FELLOWS

01/SEPT/2009 – 31/DEC/2012 3 Master Students
Department of Biochemistry, Faculty of Medicine, University of Szeged, Szeged, Hungary
01/SEPT/2013 –07/JAN/2015 3 Master Students, 2 PhD students
Department of Pharmacology and Pharmacotherapy, Faculty of Medicine, Semmelweis University, Budapest, Hungary
07/JAN/2015 – 11/JAN/2018 2 Postbac students, 1 undergraduate student
Laboratory of Cardiovascular Physiology and Tissue Injury, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD., USA
01/FEB/2018 – 2 PhD students, 2 Predoctoral students
Department of Pharmacology and Pharmacotherapy, Faculty of Medicine, Semmelweis University, Budapest, Hungary

TEACHING ACTIVITIES

01/SEPT/2005 – 31/AUG/2012 Department of Biochemistry, Faculty of Medicine, University of Szeged, Szeged, Hungary: Seminar and practical teacher of 2nd year medical students (Hungarian, German and English)
01/SEPT/2012 – 07/JAN/2015 Department of Pharmacology and Pharmacotherapy, Faculty of Medicine, Semmelweis University, Budapest, Hungary: Seminar and practical teacher of 4th year medical students (Hungarian, and English)
01/SEPT/2018 – Department of Pharmacology and Pharmacotherapy, Faculty of Medicine, Semmelweis University, Budapest, Hungary: Seminar and practical teacher of 4th year medical students (Hungarian, and English)

Publications

  1. Matyas C, Erdelyi K, Trojnar E, Zhao S, Varga ZV, Paloczi J, Mukhopadhyay P, Nemeth BT, Haskó G, Cinar R, Rodrigues RM, Ait Ahmed Y, Gao B, Pacher P. Interplay of liver-heart inflammatory axis and cannabinoid 2 receptor signalling in an experimental model of hepatic cardiomyopathy. Hepatology. 2019 Aug 30. [IF: 14.971]
  2. Lukovic D, Gugerell A, Zlabinger K, Winkler J, Pavo N, Baranyai T, Giricz Z, Varga ZV, Riesenhuber M, Spannbauer A, Traxler D, Jakab A, Garamvölgyi R, Petnehazy Ö, Pils D, Tóth L, Schulz R, Ferdinandy P, Gyöngyösi M. Transcriptional Alterations by Ischaemic Postconditioning in a Pig Infarction Model: Impact on Microvascular Protection. Int J Mol Sci. 2019 Jan 15;20(2). [IF: 4.183]
  3. Ferdinandy P, Baczkó I, Bencsik P, Giricz Z, Görbe A, Pacher P, Varga ZV, Varró A, Schulz R. Definition of hidden drug cardiotoxicity: paradigm change in cardiac safety testing and its clinical implications. Eur Heart J. 2018 Jul 2. [IF: 23.425]
  4. Ágg B, Baranyai T, Makkos A, Vető B, Faragó N, Zvara Á, Giricz Z, Veres DV, Csermely P, Arányi T, Puskás LG, Varga ZV*, Ferdinandy P*. MicroRNA interactome analysis predicts post-transcriptional regulation of ADRB2 and PPP3R1 in the hypercholesterolemic myocardium. Sci Rep. 2018 Jul 4;8(1):10134. [IF: 4.122]
  5. Nagy CT, Koncsos G, Varga ZV, Baranyai T, Tuza S, Kassai F, Ernyey AJ, Gyertyán I, Király K, Oláh A, Radovits T, Merkely B, Bukosza N, Szénási G, Hamar P, Mathé D, Szigeti K, Pelyhe C, Jelemenský M, Onódi Z, Helyes Z, Schulz R, Giricz Z, Ferdinandy P. Selegiline reduces adiposity induced by high-fat, high-sucrose diet in male rats. Br J Pharmacol. 2018 Jul 3. [IF: 6.81]
  6. Csóka B, Németh ZH, Szabó I, Davies DL, Varga ZV, Pálóczi J, Falzoni S, Di Virgilio F, Muramatsu R, Yamashita T, Pacher P, Haskó G. Macrophage P2X4 receptors augment bacterial killing and protect against sepsis. JCI Insight. 2018 Jun 7;3(11). [IF: 6.014]
  7. Heger J, Bornbaum J, Würfel A, Hill C, Brockmann N, Gáspár R, Pálóczi J, Varga ZV, Sárközy M, Bencsik P, Csont T, Török S, Kojonazarov B, Schermuly RT, Böngler K, Parahuleva M, Ferdinandy P, Schulz R, Euler G. JDP2 overexpression provokes cardiac dysfunction in mice. Sci Rep. 2018 May 16;8(1):7647. [IF: 4.122]
  8. Bencsik P, Kupai K, Görbe A, Kenyeres É, Varga ZV, Pálóczi J, Gáspár R, Kovács L, Weber L, Takács F, Hajdú I, Fabó G, Cseh S, Barna L, Csont T, Csonka C, Dormán G, Ferdinandy P. Development of Matrix Metalloproteinase-2 Inhibitors for Cardioprotection. Front Pharmacol. 2018 Apr 5;9:296. [IF: 3.831]
  9. Varga ZV*, Erdelyi K*, Paloczi J*, Cinar R, Zsengeller ZK, Jourdan T, Matyas C, Balazs NT, Guillot A, Xiang X, Mehal A, Hasko G, Stillman IE, Rosen S, Gao B, Kunos G, Pacher P. Disruption of renal arginine metabolism promotes kidney injury in hepatorenal syndrome. Hepatology. 2018 Apr 6. [IF: 14.971]
  10. Zhou Z, Xu MJ, Cai Y, Wang W, Jiang JX, Varga ZV, Feng D, Pacher P, Kunos G, Torok NJ, Gao B. Neutrophil-Hepatic Stellate Cell Interactions Promote Fibrosis in Experimental Steatohepatitis. Cell Mol Gastroenterol Hepatol. 2018 Jan 8;5(3):399-413.
  11. Varga ZV, Matyas C, Paloczi J, Pacher P. Alcohol Misuse and Kidney Injury: Epidemiological Evidence and Potential Mechanisms. Alcohol Res. 2017;38(2):283-288. [IF: 7.111]
  12. Jourdan T, Park JK, Varga ZV, Pálóczi J, Coffey NJ, Rosenberg AZ, Godlewski G, Cinar R, Mackie K, Pacher P, Kunos G. Cannabinoid-1 receptor deletion in podocytes mitigates both glomerular and tubular dysfunction in a mouse model of diabetic nephropathy. Diabetes Obes Metab. 2018 Mar;20(3):698-708. [IF: 6.715]
  13. Soethoudt M, Stolze SC, Westphal MV, van Stralen L, Martella A, van Rooden EJ, Guba W, Varga ZV, Deng H, van Kasteren SI, Grether U, IJzerman AP, Pacher P, Carreira EM, Overkleeft HS, Ioan-Facsinay A, Heitman LH, van der Stelt M. Selective Photoaffinity Probe That Enables Assessment of Cannabinoid CB2 Receptor Expression and Ligand Engagement in Human Cells. J Am Chem Soc. 2018 Feb 16. [IF: 13.858]
  14. Varga ZV, Ágg B, Ferdinandy P. miR-125b is a protectomiR: A rising star for acute cardioprotection. J Mol Cell Cardiol. 2018 Feb;115:51-53. [IF: 5.68]
  15. Valenta I*, Varga ZV*, Valentine H, Cinar R, Horti A, Mathews WB, Dannals RF, Steele K, Kunos G, Wahl RL, Pomper MG, Wong DF, Pacher P, Schindler TH. Feasibility Evaluation of Myocardial Cannabinoid Type 1 Receptor Imaging in Obesity: A Translational Approach. JACC Cardiovasc Imaging. 2018 Feb;11(2 Pt 2):320-332. [IF: 10.189]
  16. Koncsos G, Varga ZV, Baranyai T, Ferdinandy P, Schulz R, Giricz Z, Boengler K. Nagarse treatment of cardiac subsarcolemmal and interfibrillar mitochondria leads to artefacts in mitochondrial protein quantification. J Pharmacol Toxicol Methods. 2018 Jan 31;91:50-58. [IF: 2.24]
  17. Varga ZV*, Pipicz M*, Baán JA, Baranyai T, Koncsos G, Leszek P, Kuśmierczyk M, Sánchez-Cabo F, García-Pavía P, Brenner GJ, Giricz Z, Csont T, Mendler L, Lara-Pezzi E, Pacher P, Ferdinandy P. Alternative Splicing of NOX4 in the Failing Human Heart. Front Physiol. 2017 Nov 22;8:935. [IF: 4.13]
  18. Rajtik T, Goncalvesova E, Varga ZV, Leszek P, Kusmierczyk M, Hulman M, Kyselovic J, Ferdinandy P, Adameova A. Posttranslational modifications of calcium/calmodulin-dependent protein kinase IIδ and its downstream signaling in human failing hearts. Am J Transl Res. 2017 Aug 15;9(8):3573-3585. [IF: 2.829]
  19. Giricz Z, Varga ZV, Koncsos G, Nagy CT, Görbe A, Mentzer RM Jr, Gottlieb RA, Ferdinandy P. Autophagosome formation is required for cardioprotection by chloramphenicol. Life Sci. 2017 Oct 1;186:11-16. [IF: 2.936]
  20. Csóka B, Törő G, Vindeirinho J, Varga ZV, Koscsó B, Németh ZH, Kókai E, Antonioli L, Suleiman M, Marchetti P, Cseri K, Deák Á, Virág L, Pacher P, Bai P, Haskó G. A2A adenosine receptors control pancreatic dysfunction in high-fat-diet induced obesity. FASEB J. 2017 Aug 1. [IF: 5.498]
  21. Csonka C, Baranyai T, Tiszlavicz L, Fébel H, Szűcs G, Varga ZV, Sárközy M, Puskás LG, Antal O, Siska A, Földesi I, Ferdinandy P, Czakó L, Csont T. Isolated hypercholesterolemia leads to steatosis in the liver without affecting the pancreas. Lipids Health Dis. 2017 Jul 27;16(1):144. [IF: 2.073]
  22. Kemény Á, Csekő K, Szitter I, Varga ZV, Bencsik P, Kiss K, Halmosi R, Deres L, Erős K, Perkecz A, Kereskai L, László T, Kiss T, Ferdinandy P, Helyes Z. Integrative characterization of chronic cigarette smoke-induced cardiopulmonary comorbidities in a mouse model. Environ Pollut. 2017 Oct;229:746-759. [IF: 5.099]
  23. Paloczi J, Varga ZV, Hasko G, Pacher P. Neuroprotection in Oxidative Stress-Related Neurodegenerative Diseases: Role of Endocannabinoid System Modulation. Antioxid Redox Signal. 2017 Jul 18. [IF: 6.337]
  24. Szobi A, Gonçalvesová E, Varga ZV, Leszek P, Kuśmierczyk M, Hulman M, Kyselovič J, Ferdinandy P, Adameová A. Analysis of necroptotic proteins in failing human hearts. J Transl Med. 2017 Apr 28;15(1):86. [IF: 3.786]
  25. Baranyai T, Giricz Z, Varga ZV, Koncsos G, Lukovic D, Makkos A, Sárközy M, Pávó N, Jakab A, Czimbalmos C, Vágó H, Ruzsa Z, Tóth L, Garamvölgyi R, Merkely B, Schulz R, Gyöngyösi M, Ferdinandy P. In vivo MRI and ex vivo histological assessment of the cardioprotection induced by ischemic preconditioning, postconditioning and remote conditioning in a closed-chest porcine model of reperfused acute myocardial infarction: importance of microvasculature. J Transl Med. 2017 Apr 1;15(1):67. [IF: 3.786]
  26. Giricz Z, Koncsos G, Rajtík T, Varga ZV, Baranyai T, Csonka C, Szobi A, Adameová A, Gottlieb RA, Ferdinandy P. Hypercholesterolemia downregulates autophagy in the rat heart. Lipids Health Dis. 2017 Mar 23;16(1):60. [IF: 2.073]
  27. Pipicz M, Kocsis GF, Sárváry-Arantes L, Bencsik P, Varga ZV, Ferdinandy P, Csont T. Low-Dose Endotoxin Induces Late Preconditioning, Increases Peroxynitrite Formation, and Activates STAT3 in the Rat Heart. Molecules. 2017 Mar 8;22(3). [IF: 2.861]
  28. Varga ZV, Matyas C, Erdelyi K, Cinar R, Nieri D, Chicca A, Nemeth BT, Paloczi J, Lajtos T, Corey L, Hasko G, Gao B, Kunos G, Gertsch J, Pacher P. Beta-caryophyllene protects against alcoholic steatohepatitis by attenuating inflammation and metabolic dysregulation in mice. Br J Pharmacol. 2017 Jan 20. [IF:6. 81]
  29. Ramirez T, Li YM, Yin S, Xu MJ, Feng D, Zhou Z, Zang M, Mukhopadhyay P, Varga ZV, Pacher P, Gao B, Wang H. Aging aggravates alcoholic liver injury and fibrosis in mice by downregulating Sirtuin 1 expression. J Hepatol. 2017 Mar;66(3):601-609. [IF:14. 911]
  30. Mukhopadhyay P, Horváth B, Rajesh M, Varga ZV, Gariani K, Ryu D, Cao Z, Holovac E, Park O, Zhou Z, Xu MJ, Wang W, Godlewski G, Paloczi J, Nemeth BT, Persidsky Y, Liaudet L, Haskó G, Bai P, Boulares AH, Auwerx J, Gao B, Pacher P. PARP inhibition protects against alcoholic and nonalcoholic steatohepatitis. J Hepatol. 2017 Mar;66(3):589-600. [IF:14. 911]
  31. Nemeth BT, Varga ZV, Wu WJ, Pacher P. Trastuzumab cardiotoxicity: from clinical trials to experimental studies. Br J Pharmacol. 2016 Oct 7. [IF:6.81]
  32. Koncsos G*, Varga ZV*, Baranyai T, Boengler K, Rohrbach S, Li L, Schluter KD, Schreckenberg R, Radovits T, Oláh A, Mátyás C, Lux Á, Al-Khrasani M, Komlódi T, Bukosza N, Máthé D, Deres L, Barteková M, Rajtík T, Adameová A, Szigeti K, Hamar P, Helyes Z, Tretter L, Pacher P, Merkely B, Giricz Z, Schulz R, Ferdinandy P. Diastolic dysfunction in prediabetic male rats: role of mitochondrial oxidative stress. Am J Physiol Heart Circ Physiol. 2016 Oct 1;311(4):H927-H943. [IF:3.324]
  33. Gáspár R, Pipicz M, Hawchar F, Kovács D, Djirackor L, Görbe A, Varga ZV, Kiricsi M, Petrovski G, Gácser A, Csonka C, Csont T. The cytoprotective effect of biglycan core protein involves toll-like receptor 4 signaling in cardiomyocytes. J Mol Cell Cardiol. 2016 Oct;99:138-150. [IF:4.874]
  34. Pálóczi J, Varga ZV, Apáti Á, Szebényi K, Sarkadi B, Madonna R, De Caterina R, Csont T, Eschenhagen T, Ferdinandy P, Görbe A. Exogenous Nitric Oxide Protects Human Embryonic Stem Cell-Derived Cardiomyocytes against Ischemia/Reperfusion Injury. Oxid Med Cell Longev. 2016; 2016:4298945. [IF:4.492]
  35. Mátyás C, Varga ZV, Mukhopadhyay P, Paloczi J, Lajtos T, Erdelyi K, Nemeth BT, Nan M, Hasko G, Gao B, Pacher P. Chronic plus binge ethanol feeding induces myocardial oxidative stress, mitochondrial and cardiovascular dysfunction and steatosis. Am J Physiol Heart Circ Physiol. 2016 Apr 22. [IF:3.88]
  36. Lee WS, Erdelyi K, Matyas C, Mukhopadhyay P, Varga ZV, Liaudet L, Haskó G, Čiháková D, Mechoulam R, Pacher P. Cannabidiol limits Tcell-mediated chronic autoimmune myocarditis: implications to autoimmune disorders and organ transplantation. Mol Med. 2016 Jan 8. [IF:4.508]
  37. Baranyai T, Nagy CT, Koncsos G, Onódi Z, Károlyi-Szabó M, Makkos A, Varga ZV, Ferdinandy P, Giricz Z. Acute hyperglycemia abolishes cardioprotection by remote ischemic perconditioning. Cardiovasc Diabetol. 2015 Nov 18;14:151. [IF: 4.015]
  38. Varga ZV, Ferdinandy P, Liaudet L, Pacher P. Drug-induced mitochondrial dysfunction and cardiotoxicity. Am J Physiol Heart Circ Physiol. 2015 Nov;309(9):H1453-67. [IF:3.88]
  39. Görbe A, Eder A, Varga ZV, Pálóczi J, Hansen A, Ferdinandy P, Eschenhagen T. Protection by the NO-Donor SNAP and BNP against Hypoxia/Reoxygenation in Rat Engineered Heart Tissue. PLoS One. 2015. 10: e0132186. [IF:3.234]
  40. Madonna R, Cadeddu C, Deidda M, Giricz Z, Madeddu C, Mele D, Monte I, Novo G, Pagliaro P, Pepe A, Spallarossa P, Tocchetti CG, Varga ZV, Zito C, Geng YJ, Mercuro G, Ferdinandy P. Cardioprotection by gene therapy: A review paper on behalf of the Working Group on Drug Cardiotoxicity and Cardioprotection of the Italian Society of Cardiology. Int J Cardiol. 2015. 191: 203-210. [IF:6.175]
  41. Varga ZV, Giricz Z, Bencsik P, Madonna R, Gyöngyösi M, Schulz R, Mayr M, Thum T, Puskás LG, Ferdinandy P. Functional genomics of cardioprotection by ischemic conditioning and the influence of comorbid conditions: implications in target identification. Curr Drug Targets. 2015 Apr 27. [IF:3.597]
  42. Pipicz M*, Varga ZV*, Kupai K, Gáspár R, Kocsis GF, Csonka C, Csont T.: Rapid ventricular pacing-induced postconditioning attenuates reperfusion injury: effects on peroxynitrite, RISK and SAFE pathways. Br J Pharmacol. 2015 Apr 1. [IF:4,599]
  43. Baán JA*, Varga ZV*, Leszek P, Kuśmierczyk M, Baranyai T, Dux L, Ferdinandy P, Braun T, Mendler L.: Myostatin and IGF-I signaling in end-stage human heart failure: a qRT-PCR study. J Transl Med. 2015, 13:1. [IF:3.99]
  44. Pechánová O, Varga ZV, Cebová M, Giricz Z, Pacher P, Ferdinandy P.: Cardiac NO signalling in the metabolic syndrome. Br J Pharmacol. 2014 Oct 8. [IF:4.99]
  45. Pavo N, Emmert MY, Giricz Z, Varga ZV, Ankersmit HJ, Maurer G, Hoerstrup SP, Ferdinandy P, Wu JC, Gyöngyösi M.: On-line visualization of ischemic burden during repetitive ischemia/reperfusion. JACC Cardiovasc Imaging. 2014, 7: 956-8. [IF:10.189]
  46. Sárközy M, Fekete V, Szűcs G, Török S, Szűcs C, Bárkányi J, Varga ZV, Földesi I, Csonka C, Kónya C, Csont T, Ferdinandy P.: Anti-diabetic effect of a preparation of vitamins, minerals and trace elements in diabetic rats: a gender difference. BMC Endocr Disord. 2014, 14:72 [IF:1.67]
  47. Varga ZV, Giricz Z, Liaudet L, Haskó G, Ferdinándy P, Pacher P.: Interplay of oxidative, nitrosative/nitrative stress, inflammation, cell death and autophagy in diabetic cardiomyopathy. Biochim Biophys Acta. 2015, 1852: 232-42. [IF:5.089]
  48. Varga ZV, Zvara A, Faragó N, Kocsis GF, Pipicz M, Gáspár R, Bencsik P, Görbe A, Csonka C, Puskas LG, Thum T, Csont T, Ferdinandy P.: MicroRNAs associated with ischemia/reperfusion injury and cardioprotection by ischemic pre- and postconditioning: ProtectomiRs. Am J Physiol Heart Circ Physiol. 2014, 307: H216-27 [IF:4.012]
  49. Giricz Z, Varga ZV, Baranyai T, Sipos P, Pálóczi K, Kittel A, Buzás E, Ferdinandy P.: Cardioprotection by remote ischemic preconditioning of the rat heart is mediated by extracellular vesicles. J Mol Cell Cardiol. 2014. 68:75-8. [IF: 5.218]
  50. Bencsik P, Pálóczi J, Kocsis GF, Pipis J, Belecz I, Varga ZV, Csonka C, Görbe A, Csont T, Ferdinandy P.: Moderate inhibition of myocardial matrix metalloproteinase-2 by ilomastat is cardioprotective. Pharmacol Res. 2014. 80:36-42. [IF: 3.976]
  51. A. Görbe, Z.V. Varga, N. Klincumhom, T. Eschenhagen, J. Pálóczi, M. K. Pirity, A. Dinnyés, S. Rungarunlert, R. Madonna, T. Csont, P. Ferdinandy: Cytoprotection by the NO-donor SNAP against ischemia/reoxygenation injury in mouse embryonic stem cell-derived cardiomyocytes. Mol Biotechnol. 2014. 56:258-64 [IF:2.275]
  52. Varga ZV, Kupai K, Szűcs G, Gáspár R, Pálóczi J, Faragó N, Zvara A, Puskás LG, Rázga Z, Tiszlavicz L, Bencsik P, Görbe A, Csonka C, Ferdinandy P, Csont T.: MicroRNA-25-dependent up-regulation of NADPH oxidase 4 (NOX4) mediates hypercholesterolemia-induced oxidative/nitrative stress and subsequent dysfunction in the heart. J Mol Cell Cardiol. 2013. 62:111-21. [IF: 5.218]
  53. Kocsis GF, Sárközy M, Bencsik P, Pipicz M, Varga ZV, Paloczi J, Csonka C, Ferdinandy P, Csont T.: Preconditioning protects the heart in a prolonged uremic condition. Am J Physiol Heart Circ Physiol. 2012. 303:H1229-36. [IF:3.629]
  54. Faragó N, Zvara A, Varga Z, Ferdinandy P, Puskás LG.: Purification of high-quality micro RNA from the heart tissue. Acta Biol Hung. 2011. 62:413-25. [IF: 0.593]
  55. Görbe A, Varga ZV, Kupai K, Bencsik P, Kocsis GF, Csont T, Boengler K, Schulz R, Ferdinandy P.: Cholesterol diet leads to attenuation of ischemic preconditioning-induced cardiac protection: the role of connexin 43. Am J Physiol Heart Circ Physiol. 2011. 300:H1907-13. [IF: 3.708]
  56. Csont T, Görbe A, Bereczki E, Szunyog A, Aypar E, Tóth ME, Varga ZV, Csonka C, Fülöp F, Sántha M, Ferdinandy P.: Biglycan protects cardiomyocytes against hypoxia/reoxygenation injury: role of nitric oxide. J Mol Cell Cardiol. 2010. 48:649-52. [IF: 5.499]

Contact

This website uses cookies. For more information visit the Cookies & Privacy Policy page.